Acolbifene () (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator (SERM) which, as of 2015, is in phase III clinical trials for the treatment of breast cancer.
See also Acolbifene/prasterone List of investigational sex-hormonal agents § Estrogenics
References
External links Acolbifene - AdisInsight